Coherus Oncology (CHRS) Other Non-Current Liabilities (2013 - 2026)
Coherus Oncology's Other Non-Current Liabilities came in at $17.59 million for Q2 2026, up 5.1% from $16.74 million a year earlier and up 3.7% from the prior quarter.
Powered by 
Analysis
Coherus Oncology (CHRS) Other Non-Current Liabilities (2013 - 2026) Analysis & Trends
At the end of FY2025, Coherus Oncology's Other Non-Current Liabilities was $19.89 million, down 32.2% from FY2024.
- Other Non-Current Liabilities carries a five-year compound annual growth rate of 80.1% (FY2020 to FY2025).
- Going back by year, Other Non-Current Liabilities was $29.33 million in FY2024 (+133.5%), $12.56 million in FY2023 (+262.3%), $3.47 million in FY2022 (+362.3%) and $750,000 in FY2021 (-28.6%).
- The five-year range for quarterly Other Non-Current Liabilities is $102,000 (Q1 2022) to $31.29 million (Q1 2025).
- Year-over-year, Other Non-Current Liabilities increased in three of the last seven quarters, with growth averaging 101.6%.
- The fastest year-over-year change in Other Non-Current Liabilities over five years came in Q3 2024 (growth of 730.1%), and the weakest in Q2 2022 (a decline of 86.4%).
- Business Quant data shows CHRS's Other Non-Current Liabilities at $16.97 million (Q1 2026), $19.89 million (Q4 2025) and $17.55 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn |
| 10 | Coherus Oncology | 155.59 Mn | -480.55 Mn | 10.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.59 Mn |
| Mar 31, 2026 | 16.97 Mn |
| Dec 31, 2025 | 19.89 Mn |
| Sep 30, 2025 | 17.55 Mn |
| Jun 30, 2025 | 16.74 Mn |
| Mar 31, 2025 | 31.29 Mn |
| Dec 31, 2024 | 29.33 Mn |
| Sep 30, 2024 | 29.16 Mn |
| Jun 30, 2024 | 27.70 Mn |
| Mar 31, 2024 | 2.73 Mn |
| Dec 31, 2023 | 12.56 Mn |
| Sep 30, 2023 | 3.51 Mn |
| Jun 30, 2023 | 102,000.00 |
| Mar 31, 2023 | 102,000.00 |
| Dec 31, 2022 | 3.47 Mn |
| Sep 30, 2022 | 102,000.00 |
| Jun 30, 2022 | 102,000.00 |
| Mar 31, 2022 | 102,000.00 |
| Dec 31, 2021 | 750,000.00 |
| Sep 30, 2021 | 750,000.00 |
API Access
Coherus Oncology Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();